Trials / Unknown
UnknownNCT01400360
Invasive Diagnostic and Therapeutic Management of Cerebral Vasospasm After Aneurysmatic Subarachnoid Hemorrhage
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 92 (estimated)
- Sponsor
- Johann Wolfgang Goethe University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Cerebral vasospasm(CVS) after subarachnoid hemorrhage (SAH) results in a considerable amount of transient or even permanent neurological deficits and poor outcome of the patients. Transluminal Balloon angioplasty (TBA) or intraarterial application of vasodilators represents a rescue therapy for severe CVS. Indication, duration and efficacy of this treatment, however, is still under debate. Aim of the study is to investigate if such a rescue treatment can significantly reduce new delayed ischemic cerebral deficits after SAH. Hypothesis is that the occurance of delayed infarcts can be reduced by repetetive intraarterial therapy to more than 50 %.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Combination of TBA and intraarterial application of vasodilators | In the invasive arm CVS should be treated by intraarterial therapy and efficacy controlled by CT or MRI after 48 hours and if necessary repeated. |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2011-08-01
- First posted
- 2011-07-22
- Last updated
- 2011-07-22
Locations
5 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01400360. Inclusion in this directory is not an endorsement.